VIVUS, Inc. (Nasdaq: VVUS) may be lowering the price of its Qsymia just months after commercialization began.

According to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE